Biocon Adds To A Crowded Field For US Denosumab

Biosimilars To Prolia And Xgeva Represent Sixth Pair Approved In US

 
• By Dave Wallace
  
Biocon’s Bosaya and Aukelso join five other US denosumab pairs (Shutterstock)

More from Biosimilars

More from Products